Registration
ARNOLD & PORTER KAYE SCHOLER LLP for ALVOGEN
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to domestic manufacturing of pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINE BLACKWOOD New | Deputy Dir. for Cong. Oversight, HHS (2010-15); Chief Counsel, Senate Aging (09-10); Investigative Counsel, House E&C (07-08); Attorney-Advisor, DOJ Leg Affairs (05-07); Healthcare Fraud Coordinator, DOJ (03-05); AUSA, Central District CA (94-03) |
| PARI MODY New | Intern, HHS Office of General Counsel Public Health (2013) |
| EUGENIA PIERSON New | House Energy and Commerce Committee (2001-05) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ALVOGEN LUX HOLDINGS SARL | Luxembourg | Luxembourg | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.